Revive Therapeutics Ltd. (CSE: RVV)

Revive Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 19, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	2	4	16	148	187	55
Market Cap Growth	-70.74%	-73.99%	-89.09%	-21.23%	240.94%	698.49%
Enterprise Value	2	3	14	143	169	55
Last Close Price	0.01	0.01	0.04	0.46	0.59	0.29
PB Ratio	0.31	0.58	1.51	11.70	6.50	7.39
P/TBV Ratio	-	-	-	1436.11	11.48	28.47
Debt / Equity Ratio	-	0.00	0.02	0.03	0.01	0.06
Quick Ratio	0.09	0.24	0.65	0.99	27.99	4.46
Current Ratio	0.16	0.34	0.68	1.00	28.11	5.80
Return on Equity (ROE)	-66.98%	-62.83%	-54.36%	-86.00%	-111.04%	-128.29%
Return on Assets (ROA)	-18.27%	-16.52%	-22.05%	-47.58%	-60.99%	-48.28%
Return on Capital (ROIC)	-25.29%	-22.68%	-29.02%	-52.90%	-62.55%	-52.02%
Earnings Yield	-288.10%	-134.24%	-39.27%	-12.07%	-10.74%	-9.80%
FCF Yield	-78.01%	-78.62%	-37.44%	-8.85%	-4.44%	-4.58%
Buyback Yield / Dilution	-13.80%	-12.11%	-6.13%	-19.54%	-150.28%	-67.08%
Total Shareholder Return	-13.80%	-12.11%	-6.13%	-19.54%	-150.28%	-67.08%

Source: S&P Capital IQ. Standard template. Financial Sources.